Skip to main content
. 2022 Jan 11;28:e934100-1–e934100-13. doi: 10.12659/MSM.934100

Table 2.

Relationship between plasma tHcy levels or MS and the prevalence of stroke in different models.

Variables Event, n (%) Crude Model Model I Model II
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
tHcy (μmol/L)
 Per SD increase 960 (6.83%) 1.18 (1.12, 1.23) <0.001 1.13 (1.07, 1.19) <0.001 1.08 (1.02, 1.14) 0.010a
tHcy (μmol/L)
 <15 367 (5.22%) Ref Ref Ref
 ≥15 593 (8.44%) 1.68 (1.46, 1.92) <0.001 1.48 (1.28, 1.71) <0.001 1.36 (1.17, 1.58) <0.001a
tHCY tertile (μmol/L)
 T1 [5.88, 13.23] 231 (4.93%) Ref Ref Ref
 T2 [13.24, 17.37] 307 (6.54%) 1.35 (1.13, 1.61) <0.001 1.24 (1.04, 1.49) 0.017 1.28 (1.06, 1.53) 0.009b
 T3 [17.38, 134.50] 422 (9.00%) 1.91 (1.62, 2.25) <0.001 1.62 (1.36, 1.94) <0.001 1.49 (1.23, 1.81) <0.001b
tHcy quartile (μmol/L)
 Q1 [5.88, 12.46] 176 (5.02%) Ref Ref Ref
 Q2 [12.47, 15.00] 191 (5.41%) 1.08 (0.88, 1.34) 0.459 1.01 (0.82, 1.25) 0.922 1.04 (0.84, 1.29) 0.709c
 Q3 [15.01, 19.11] 268 (7.60%) 1.56 (1.28, 1.89) <0.001 1.38 (1.13, 1.69) 0.002 1.37 (1.11, 1.69) 0.003c
 Q4 [19.12, 134.50] 326 (9.27%) 1.93 (1.60, 2.34) <0.001 1.61 (1.31, 1.97) <0.001 1.49 (1.19, 1.85) <0.001c
P for trend <0.001 <0.001 <0.001
MS
 No 490 (6.03%) Ref Ref Ref
 Yes 470 (7.92%) 1.34 (1.18, 1.53) <0.001 1.58 (1.38, 1.81) <0.001 1.68 (1.44, 1.96) <0.001d
No. of MS components
 One 256 (6.32%) Ref Ref Ref
 Two 234 (5.75%) 0.90 (0.75, 1.09) 0.278 1.01 (0.84, 1.21) 0.935 1.09 (0.90, 1.32) 0.394e
 Three 257 (7.53%) 1.21 (1.01, 1.44) 0.039 1.47 (1.22, 1.77) <0.001 1.74 (1.41, 2.13) <0.001e
 Four 158 (7.97%) 1.28 (1.04, 1.58) 0.018 1.64 (1.32, 2.03) <0.001 1.99 (1.56, 2.54) <0.001e
 Five 55 (10.22%) 1.69 (1.24, 2.29) <0.001 2.22 (1.62, 3.04) <0.001 2.60 (1.84, 3.67) <0.001e
P for trend <0.001 <0.001 <0.001

tHcy – total homocysteine; MS – metabolic syndrome; Ref – reference; OR – odds ratio; CI confidence interval; SD – standard deviation. Model I adjusted for age and sex. Model II:

a

adjusted for sex, smoking and drinking status, eGFR, reduced HDL-C and abdominal obesity.

b

adjusted for a + serum uric acid.

c

adjusted for b + age and elevated TG.

d

adjusted for age, sex, BMI, smoking and drinking status, eGFR and tHcy.

e

adjusted for d + heart rate and serum uric acid.